Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 68001-642

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 68001-642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Decitabine For Inj 50mg Per Vial Carton Ndc 6800164241 Rev 112024 (Decitabine For Inj 50mg Per Vial Carton Ndc 6800164241 Rev 112024)

Decitabine For Inj 50mg Per Vial Carton Ndc 6800164241 Rev 112024 (Decitabine For Inj 50mg Per Vial Carton Ndc 6800164241 Rev 112024)
Packaging label for Decitabine injection powder, lyophilized 50 mg per vial from BluePoint Laboratories. The label includes reconstitution and storage instructions, warnings about cytotoxicity, and manufacturer information for Hetero Labs Limited. It is labeled for intravenous infusion only and includes the NDC code 68001-642-41.*
FDA Label Image

Decitabine For Inj 50mg Per Vial Label Ndc 6800164241 Rev 112024 (Decitabine For Inj 50mg Per Vial Label Ndc 6800164241 Rev 112024)

Decitabine For Inj 50mg Per Vial Label Ndc 6800164241 Rev 112024 (Decitabine For Inj 50mg Per Vial Label Ndc 6800164241 Rev 112024)
Label for Decitabine injection powder, lyophilized, for solution, 50 mg per vial for intravenous infusion. Manufactured by Hetero Labs Limited for BluePoint Laboratories. Includes ingredient details, storage conditions (20-25°C with excursions to 15-30°C), and a warning for cytotoxic agent. Features NDC 68001-642 and a barcode.*
FDA Label Image

Decitabineforinjstructure (Decitabineforinjstructure)

Decitabineforinjstructure (Decitabineforinjstructure)
Chemical structure of decitabine, depicting a nucleoside analog with a pyrimidine base attached to a sugar ring. The structure includes amino, keto, and hydroxyl functional groups characteristic of decitabine's molecular makeup.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.